# A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer

> **NCT02344095** · PHASE1 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 12 (actual)

## Conditions studied

- Epithelial Ovarian Carcinoma
- Fallopian Tube Carcinoma
- Primary Peritoneal Carcinoma

## Interventions

- **DRUG:** weekly paclitaxel
- **DRUG:** weekly cisplatin
- **DEVICE:** oncothermia

## Key facts

- **NCT ID:** NCT02344095
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02344095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02344095, "A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02344095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*